Screener
Charles River Laboratories CRL Manufacturing — Operating Income (Loss)
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 9:21 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001100682-26-000118
| Line item | Three Months Ended / June 27, 2026 | Three Months Ended / June 28, 2025 | Six Months Ended / June 27, 2026 | Six Months Ended / June 28, 2025 |
|---|---|---|---|---|
| Cost of products sold (excluding amortization of intangible assets) | 88,697 | 90,192 | 180,956 | 179,200 |
| Selling, general and administrative | 228,897 | 191,549 | 388,319 | 369,348 |
| Amortization of intangible assets | 14,589 | 65,384 | 29,934 | 130,648 |
| Operating income | 119,888 | 100,134 | 239,785 | 174,803 |
| Other income (expense) | ||||
| Interest income | 1,032 | 1,097 | 2,065 | 2,501 |
| Interest expense | (30,340) | (29,967) | (57,082) | (57,851) |
| Other (expense) income, net | (37,410) | 154 | (161,540) | (12,057) |
Item 1. Financial Statements
FAQ
- What is Charles River Laboratories's manufacturing — operating income (loss)?
- Charles River Laboratories (CRL) reported manufacturing — operating income (loss) of $65.61M in Q2 2026.
- How has Charles River Laboratories's manufacturing — operating income (loss) changed year-over-year?
- Charles River Laboratories's manufacturing — operating income (loss) increased by 444.0% year-over-year, from $12.06M to $65.61M.
- What is the long-term trend for Charles River Laboratories's manufacturing — operating income (loss)?
- Over 2 years (2023 to 2025), Charles River Laboratories's manufacturing — operating income (loss) has grown at a 44.4% compound annual growth rate (CAGR), from $88.33M to -$184.28M.
- What does manufacturing — operating income (loss) mean?
- Calculated as the segment's revenue minus its operating expenses, including cost of revenue, SG&A, and depreciation/amortization. It serves as the primary indicator of the segment's core profitability from operations.
Ask your AI about Charles River Laboratories's manufacturing — operating income (loss).
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude